Lenalidomid BMS 2
Lenalidomid BMS 2 is a medicine authorised by Swissmedic under authorisation number 68490. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 June 2021 and the authorisation is valid without a time limit. ATC code L04AX04 places the medicine in the group Immunosuppressants.
| Authorisation number | 68490 |
|---|---|
| Name | Lenalidomid BMS 2 |
| Full name | Lenalidomid BMS 2,5 mg, Hartkapseln |
| Authorisation holder | Bristol-Myers Squibb SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AX04 |
| First authorisation | 14 June 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lenalidomid BMS 2,5 mg, Hartkapseln | A | 14 June 2021 |
| 2 | Lenalidomid BMS 5 mg, Hartkapseln | A | 14 June 2021 |
| 3 | Lenalidomid BMS 7,5 mg, Hartkapseln | A | 14 June 2021 |
| 4 | Lenalidomid BMS 10 mg, Hartkapseln | A | 14 June 2021 |
| 5 | Lenalidomid BMS 15 mg, Hartkapseln | A | 14 June 2021 |
| 6 | Lenalidomid BMS 20 mg, Hartkapseln | A | 14 June 2021 |
| 7 | Lenalidomid BMS 25 mg, Hartkapseln | A | 14 June 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 2 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 3 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 4 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 5 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 6 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
| 7 | 21 | Kapsel(n) | L04AX04 | 07.16.4. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lenalidomid BMS 2 authorised in Switzerland?
Yes. Lenalidomid BMS 2 is authorised by Swissmedic under authorisation number 68490, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lenalidomid BMS 2 have?
Lenalidomid BMS 2 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Lenalidomid BMS 2?
The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.